Biocon Biologics and Viatris’s Semglee preferred on Express Scripts’ largest formulary in US Read more
Approval of first interchangeable biosimilar insulin to increase competition with payer contracts: GlobalData Read more
Mylan-UpJohn merger as Viatris provides opportunity to focus on biosimilar launch and uptake Read more